Jane Street
RCKT icon

Jane Street’s Rocket Pharmaceuticals RCKT Stock Holding History

Jane Street’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-623,354
Closed -$2.23M – 12856
2026
Q1 		$2.23M Buy
623,354
+20,774
+3% +$82.6K ﹤0.01% 4873
2025
Q4 		$2.12M Buy
602,580
+118,099
+24% +$404K ﹤0.01% 4712
2025
Q3 		$1.58M Buy
484,481
+440,213
+994% +$1.39M ﹤0.01% 5379
2025
Q2 		$108K Sell
44,268
-2,320
-5% -$11.8K ﹤0.01% 8917
2025
Q1 		$311K Buy
46,588
+6,214
+15% +$61.4K ﹤0.01% 7748
2024
Q4 		$508K Sell
40,374
-137,298
-77% -$2.07M ﹤0.01% 6750
2024
Q3 		$3.28M Buy
177,672
+47,134
+36% +$965K ﹤0.01% 3558
2024
Q2 		$2.81M Buy
+130,538
New +$3M ﹤0.01% 3915
2024
Q1 		– Sell
-48,048
Closed -$1.36M – 9925
2023
Q4 		$1.44M Buy
48,048
+12,353
+35% +$273K ﹤0.01% 4897
2023
Q3 		$731K Sell
35,695
-101,146
-74% -$1.84M ﹤0.01% 5644
2023
Q2 		$2.72M Buy
136,841
+112,289
+457% +$2.27M ﹤0.01% 3664
2023
Q1 		$421K Buy
24,552
+8,099
+49% +$159K ﹤0.01% 6612
2022
Q4 		$322K Buy
16,453
+5,107
+45% +$94K ﹤0.01% 6891
2022
Q3 		$181K Sell
11,346
-1,650
-13% -$25.7K ﹤0.01% 8266
2022
Q2 		$179K Buy
+12,996
New +$155K ﹤0.01% 8277
2022
Q1 		– Sell
-10,925
Closed -$239K – 10906
2021
Q4 		$239K Buy
10,925
+660
+6% +$18K ﹤0.01% 8548
2021
Q3 		$307K Buy
10,265
+5,377
+110% +$196K ﹤0.01% 8135
2021
Q2 		$216K Sell
4,888
-14,329
-75% -$622K ﹤0.01% 8694
2021
Q1 		$853K Sell
19,217
-1,518
-7% -$83.4K ﹤0.01% 5761
2020
Q4 		$1.14M Buy
20,735
+882
+4% +$32.2K ﹤0.01% 4432
2020
Q3 		$454K Buy
+19,853
New +$489K ﹤0.01% 5302

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Jane Street's RCKT Position: Q2 2026 in Review

Jane Street sold out of Rocket Pharmaceuticals (RCKT) in Q2 2026, closing a stake of 623,354 shares — an estimated $2.23M sold.

Jane Street first reported a position in RCKT in Q3 2020 and held it in 21 quarters. The position peaked at $3.28M in Q3 2024. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Jane Street reported no remaining Rocket Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 623,354 Rocket Pharmaceuticals shares in Q2 2026, an estimated $2.23M.
  • Jane Street first reported a position in Rocket Pharmaceuticals in Q3 2020 and held it in 21 quarters.
  • Jane Street's Rocket Pharmaceuticals position peaked at $3.28M in Q3 2024.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.